SPONSOR
Robert Olson
Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Oligometastatic DiseaseOligoprogressionToxicity Due to RadiotherapyQuality of Life
Robert Olson is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy, Quality of Life.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Robert Olson
How many clinical trials has Robert Olson sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Robert Olson, of which 1 are actively recruiting participants. These trials cover conditions including Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Robert Olson research focus on?
Robert Olson clinical trials span Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy, Quality of Life. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Robert Olson clinical trial?
To participate in a Robert Olson trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Robert Olson trials with current recruitment status updated daily.
Clinical Trials by Robert Olson
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology